SCHEMBL19217080

SCHEMBL19217080

c1ccc2oc(-c3ccc4cc(-c5ccc6cc[nH]c6c5)sc4c3)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.42
MAOB P27338 3/20 0.41
IKBKB O14920 1/20 0.41
CHUK O15111 1/20 0.41
ADRA2A P08913 2/20 0.40
MAOA P21397 2/20 0.39
PTPRC P08575 1/20 0.39
PTPN1 P18031 1/20 0.39
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
APP P05067 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
NFKB1 P19838 1/20 0.35
NPY1R P25929 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19346119 0.92 HDAC6 (0.43) ALOX5MAOBIKBKBCHUKADRA2A
SCHEMBL20466823 0.92 HDAC6 (0.43) ALOX5MAOBIKBKBCHUKADRA2A
SCHEMBL20417352 0.91 APP (0.41) ALOX5MAOBIKBKBCHUKADRA2A
SCHEMBL22363333 0.90 APP (0.40) ALOX5MAOBIKBKBCHUKADRA2A
SCHEMBL7088340 0.86 ALOX5 (0.54) ALOX5MAOBIKBKBCHUKADRA2A
SCHEMBL22222028 0.84 HDAC6 (0.52) ALOX5MAOBIKBKBCHUKADRA2A
SCHEMBL19368366 0.82 KDM4E (0.49) ALOX5MAOBADRA2ACA1CA2
SCHEMBL22100552 0.82 FGFR1 (0.45) ALOX5MAOBADRA2AMAOAPTPRC
SCHEMBL23206844 0.81 ALOX5 (0.44) ALOX5MAOBIKBKBCHUKADRA2A
SCHEMBL13201332 0.81 APP (0.53) CA1CA2CA9NPC1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174531-A1 SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. 2023-06-08 US disclosed
US-20230125803-A1 ANTIVIRAL HETEROCYCLIC COMPOUNDS ENANTA PHARM INC (US) 2023-04-27 US disclosed
US-20230115701-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES UNIV ARIZONA STATE (US) 2023-04-13 US disclosed
US-11572367-B2 Antiviral heterocyclic compounds ENANTA PHARMACEUTICALS, INC. (US) 2023-02-07 US disclosed
US-11011712-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-05-18 US disclosed
US-20210024559-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES UNIV ARIZONA STATE (US) 2021-01-28 US disclosed
US-10434052-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles SAMUMED, LLC (US) 2019-10-08 US disclosed
US-20180226593-A1 Tetradentate Cyclometalated Platinum Complexes Containing 9,10-Dihydroacridine And Its Analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2018-08-09 US disclosed
US-20180193244-A1 GAMMA-DIKETONES FOR TREATMENT AND PREVENTION OF AGING SKIN AND WRINKLES VICKERS VENTURE FUND VI PTE. LTD. (SG) 2018-07-12 US disclosed
US-9941479-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-04-10 US disclosed
US-20170226129-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180226593-A1 Tetradentate Cyclometalated Platinum Complexes Containing 9,10-Dihydroacridine And Its Analogues DPYD, DCTD, TYMP ALOX5 4712/4885MAOB 4328/4885IKBKB 4431/4885
US-20180193244-A1 GAMMA-DIKETONES FOR TREATMENT AND PREVENTION OF AGING SKIN AND WRINKLES GLA, DGKG, DGKA ALOX5 305/4885MAOB 1378/4885IKBKB 771/4885
US-11011712-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues DPYD, DCTD, TYMP ALOX5 4712/4885MAOB 4328/4885IKBKB 4431/4885
US-20170226129-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS SIRT1, FURIN, SIRT5 ALOX5 957/4885MAOB 577/4885IKBKB 259/4885
US-20230115701-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES PAICS, DNTT, PNPO ALOX5 2126/4885MAOB 2645/4885IKBKB 1911/4885
US-20230174531-A1 SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS ACE, ACE2, PKD1 ALOX5 1214/4885MAOB 3443/4885IKBKB 100/4885
US-11572367-B2 Antiviral heterocyclic compounds ACE, HPRT1, ACE2 ALOX5 620/4885MAOB 957/4885IKBKB 717/4885
US-20230125803-A1 ANTIVIRAL HETEROCYCLIC COMPOUNDS ACE, HPRT1, ACE2 ALOX5 620/4885MAOB 957/4885IKBKB 717/4885
US-10434052-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles GLA, DGKA, DGKG ALOX5 730/4885MAOB 1704/4885IKBKB 624/4885
US-20210024559-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES PAICS, DNTT, PNPO ALOX5 2126/4885MAOB 2645/4885IKBKB 1911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.